Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial-Reference-Cited by-同舟云学术

Subject‐driven titration of biphasic insulin aspart 30 twice daily is non‐inferior to investigator‐driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open‐label, parallel‐group, multicenter trial

Published:2015-05-25 Issue:1 Volume:7 Page:85-93
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Yang Wenying¹,Zhu Lvyun²,Meng Bangzhu³,Liu Yu⁴,Wang Wenhui⁵,Ye Shandong⁶,Sun Li⁷,Miao Heng⁸,Guo Lian⁹,Wang Zhanjian¹⁰,Lv Xiaofeng¹¹,Li Quanmin¹²,Ji Qiuhe¹³,Zhao Weigang¹⁴,Yang Gangyi¹⁵

Affiliation:

1. China‐Japan Friendship Hospital Beijing China

2. Bethune International Peace Hospital Shijiazhuang China

3. Affiliated Hospital of Inner Mongolia University for the Nationalities Tongliao China

4. The Second Hospital of Jilin University Changchun China

5. Jinan Central Hospital Affiliated to Shandong University Jinan China

6. Anhui Provincial Hospital Hefei China

7. Siping Central People's Hospital Siping China

8. The Second Affiliated Hospital of Nanjing Medical University Nanjing China

9. Chongqing Three Gorges Central Hospital Chongqing China

10. The Third Affiliated Hospital of Hebei Medical University Shijiazhuang China

11. The Military General Hospital of Beijing PLA Beijing China